期刊文献+

炎症标志物在急性冠脉综合征中的研究进展 被引量:1

Advances in Research of Inflammatory Markers in Acute Coronary Syndrome
下载PDF
导出
摘要 冠状动脉粥样硬化斑块内的炎症反应促使冠状动脉内不稳定斑块的形成和破裂,并在此基础上发生细胞成分的活化且介导血栓的形成,是大多数急性冠脉综合征发生的主要原因。炎症反应在此过程中起了关键性作用,其中产生的如C反应蛋白、白细胞介素1、6、8、肿瘤坏死因子浕、P选择素等炎症标志物参与了冠脉血管内膜急性炎症的发生、发展过程。
出处 《心血管病学进展》 CAS 2005年第B08期4-6,共3页 Advances in Cardiovascular Diseases
  • 相关文献

参考文献29

  • 1Davies M. The pathophysiology of acute coronary syndromes [ J ]. Heart, 2000,83:361-366.
  • 2Arbustini E, Morbini P, Bello BD, et al. New insights into pathophysiology of AMI:from plaque biology to clinical setting[ J ]. Arn Heart J, 1999,138:S56-S60.
  • 3程翔,廖玉华.炎症与动脉粥样硬化[J].中华心血管病杂志,2004,32(5):475-477. 被引量:87
  • 4Plutxky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes[ J ]. Am J Cardiol ,2001,88 ( Suppl ) : 10K-15K.
  • 5Torxewski J,Torzewski M, Bowyer DE,et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries [ J ] . Arterioscler Thromb Vase Biol,1998,18 : 1386-1392.
  • 6黄炜,陈清枝,燕宪亮,王然,张颖.C-反应蛋白白细胞介素-6和肿瘤坏死因子-α在冠心病中的变化[J].临床心血管病杂志,2004,20(7):398-400. 被引量:29
  • 7Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein,an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction [ J ]. JACC, 1998,32:35-41.
  • 8赵晓燕,李泉生.血浆C反应蛋白与不稳定型心绞痛危险度分级关系的探讨[J].临床心血管病杂志,2003,19(5):277-279. 被引量:22
  • 9Haverkate F, Thompson SG, Pyke SDM, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European concerted action or thrombosis and disabilities angina pectoris study group[J]. Lancet,1997,349 : 462-462.
  • 10Rifai N, Ridker PM. Inflammation substances and coronary heart disease [ J ].Curt Opin Lipid,2002,13:383-389.

二级参考文献54

  • 1牛丽丽.肿瘤坏死因子与冠心病[J].国外医学(心血管疾病分册),1994,21(6):323-325. 被引量:28
  • 2姜德谦,文丹,祁述善,沈向前,周胜华.甘油三酯与高密度脂蛋白预测冠状动脉病变的意义[J].中华内科杂志,1995,34(5):298-301. 被引量:41
  • 3[1]Ross R. Atherosclerosis--An inflammatory disease. N Engl J Med, 1999, 340:115-126.
  • 4[2]Ridker P M, Cushman M, Stampfre M J, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998, 97:425-428.
  • 5[3]Anderson J L, Carlquist J F, Joseph B, et al. Evaluation of C-reactive protein , an inflammatory marker, and infectious serology as risk factor for coronary artery disease and myocardial infarction. JACC, 1988, 32:35-35.
  • 6[4]Braunwald E. Unstable angina, a classification. Circulation, 1989, 80:410-411.
  • 7[5]Haverkate F, Thompson S G, Pyke S D M, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group. Lancet, 1997, 349:462-462.
  • 8[6]Liuzzo G, Biasucci L M, Gauinore J R, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med, 1994,331:417-424.
  • 9[1]Buffon A, Giovanna L, Luigi M, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. JACC , 1999,34:1512-1521.
  • 10[2]Walter D H, Stephan F, Marc S. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. JACC, 2001,37:839-846.

共引文献215

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部